|
Volumn 111, Issue , 2000, Pages
|
Jeremiah Metzger Lecture. Targeted cancer therapy.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
EPIDERMAL GROWTH FACTOR RECEPTOR;
MONOCLONAL ANTIBODY;
ANIMAL;
APOPTOSIS;
CELL CYCLE;
CLINICAL TRIAL;
DRUG ANTAGONISM;
HUMAN;
IMMUNOLOGY;
METASTASIS;
MULTIMODALITY CANCER THERAPY;
NEOPLASM;
NEOVASCULARIZATION (PATHOLOGY);
PATHOLOGY;
REVIEW;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
CELL CYCLE;
CLINICAL TRIALS;
COMBINED MODALITY THERAPY;
HUMANS;
NEOPLASM METASTASIS;
NEOPLASMS;
NEOVASCULARIZATION, PATHOLOGIC;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
|
EID: 0033648433
PISSN: 00657778
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (28)
|
References (60)
|